Equillium, Inc.

Equillium, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer new products with a mission to dramatically improve the lives of patients with severe autoimmune and inflammatory diseases who continue to suffer with high unmet medical needs. By bringing treatments designed to restore the balance of the immune system, we hope to restore the balance of life for patients in need. Our lead product candidate, itolizumab, is a first-in-class monoclonal antibody that targets the CD6-ALCAM signaling pathway, which plays a central role in the activation and trafficking of pathogenic effector T cells that drive inflammation in a number of diseases. We believe itolizumab may have broad therapeutic utility and our current pipeline is focused on developing itolizumab as a best-in-class treatment for multiple severe immuno-inflammatory disorders – this includes acute graft-versus-host disease, SLE / lupus nephritis and uncontrolled asthma.

Company Details

Employees
39
Founded
-
Address
2223 Avenida De La Playa, San Diego,california,united States
Phone
858 412 5302
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Diego, California
Looking for a particular Equillium, Inc. employee's phone or email?

Equillium, Inc. Questions

News

Equillium Announces Feedback from the U.S. Food and Drug Administration - Business Wire

Equillium Announces Feedback from the U.S. Food and Drug Administration Business Wire

Equillium to Participate in the Cantor Global Healthcare Conference 2025 - Yahoo Finance

Equillium to Participate in the Cantor Global Healthcare Conference 2025 Yahoo Finance

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 - Sahm

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 Sahm

Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy - Business Wire

Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy Business Wire

Equillium to Host Virtual Investor and Analyst Day on December 4, 2020 - GlobeNewswire

Equillium to Host Virtual Investor and Analyst Day on December 4, 2020 GlobeNewswire

Equillium to Host Analyst & Investor Day | User | sweetwaterreporter.com - FinancialContent

Equillium to Host Analyst & Investor Day | User | sweetwaterreporter.com FinancialContent

Top Equillium, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant